Phase 1 data. "As previously stated, Amgen does not see an association between the administration of MariTide and bone mineral density ...

Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the ...

Shortly after Amgen unveiled its $1.9 billion alliance with ... in the AI drug discovery category even before it closed a $510 million initial pubic offering last year. The company's platform ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...